Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease.
CF is a rare genetic disease found in about 30,000 people in the U.S. If you have CF or are considering testing for it, knowing about the role of genetics in CF can help you make informed decisions about your health care.
If you or your child has just been diagnosed with cystic fibrosis, or your doctor has recommended testing for CF, you may have many questions.
Diagnosing CF is a multistep process. A complete diagnostic evaluation should include a newborn screening, a sweat chloride test, a genetic or carrier test, and a clinical evaluation at a CF Foundation-accredited care center.
Raising a child with cystic fibrosis can bring up many questions because CF affects many aspects of your child’s life. Here you’ll find resources to help you manage your child’s daily needs and find the best possible CF care.
Living with cystic fibrosis comes with many challenges, including medical, social, and financial. By learning more about how you can manage your disease every day, you can ultimately help find a balance between your busy lifestyle and your CF care.
People with CF are living longer, healthier lives than ever before. As an adult with CF, you may reach key milestones you might not have considered. Planning for these life events requires careful thought as you make decisions that may impact your life.
People with cystic fibrosis are living longer and more fulfilling lives, thanks in part to specialized CF care and a range of treatment options.
Cystic Fibrosis Foundation-accredited care centers provide expert care and specialized disease management to people living with cystic fibrosis.
We provide funding for and accredit more than 120 care centers and 53 affiliate programs nationwide. The high quality of specialized care available throughout the care center network has led to the improved length and quality of life for people with CF.
The Cystic Fibrosis Foundation provides standard care guidelines based on the latest research, medical evidence, and consultation with experts on best practices.
As a clinician, you’re critical in helping people with CF maintain their quality of life. We’re committed to helping you partner with patients and their families by providing resources you can use to improve and continue to provide high-quality care.
As part of the Cystic Fibrosis Foundation's mission to help improve the lives of people living with cystic fibrosis, the PSDC initiative taps the CF community to inform key efforts to support the management of daily care.
Your cystic fibrosis care team includes a group of CF health care professionals who partner with you to provide specialized, comprehensive CF care.
Many cystic fibrosis patients and families face complicated issues related to getting the care they need. But CF Foundation Compass makes sure that no one has to do it alone.
For many people with cystic fibrosis, dealing with insurance is as much a part of living with the disease as nebulizers and vests. Many people with CF and their families face issues related to getting the care they need, but no one has to do it alone.
The Cystic Fibrosis Foundation is the world’s leader in the search for a cure for CF and supports a broad range of research initiatives to tackle the disease from all angles.
The CF Foundation offers a number of resources for learning about clinical trials and treatments that are being developed to improve the treatment of cystic fibrosis.
Our understanding of CF continues to evolve as scientists study what causes the disease and how it affects the body. These insights drive the development of new and better treatments and bring us one step closer to a cure.
Researchers, supported by the CF Foundation, have made tremendous advances to improve the health and quality of life of people with CF. We are committed to providing the tools and resources you need to continuously build upon this work.
An analysis of cystic fibrosis patient registry data from the United States and Canada found that Canadians were living about 10 years longer than Americans. Two of the study authors discuss the findings and offer some possible reasons for the results.
Christopher Goss, M.D., M.Sc.
Anne Stephenson, M.D., Ph.D.
March 13, 2017
Diagnosed Before Birth: Getting My Daughter’s CF Diagnosis
Why We Must Advocate
Updated on April 19, 2018 -- Since the original publication of this blog post, a study has been published in the March 2018 issue of a journal published by the American Thoracic Society. The results support preliminary findings (described below) where a survival gap between people with CF in the United States and Canada is narrowing within younger age groups. Although there have been improvements in nutritional status and lung function for both Americans and Canadians with CF, Americans born after 1990 have higher BMI, an improvement that has continued over time.
Our analysis, a comparison of patient registry data that was published on the Annals of Internal Medicine website, found that the median age of survival for people with cystic fibrosis in the United States and Canada has increased over time; however, Canadians with CF were living on average about 10 years longer than their U.S. counterparts. We offer some possible explanations for these findings, which may help improve care for people in the U.S.
With funding from the Cystic Fibrosis Foundation, we began the study after looking at the patient registry reports for both countries in 2011. The Foundation's Patient Registry showed differences in the median survival age when compared to the Canadian Registry. The way registry data is entered and analyzed can differ between countries, which can make a direct comparison difficult. We did not know how much of an impact the differences had on this gap, and we sought to determine whether combining the data and using the same approach to calculate survival would affect these differences.
The U.S. and Canadian CF patient registries collect a range of health information about people with CF who agree to participate in them. This information is used to study health trends in the CF patient population, inform how care is provided, design clinical trials, and guide quality improvement work at care centers.
First, the good news: The study found that the median age of survival for people with CF in the U.S. and Canada is improving -- but more so for Canadians. The first question to ask is, “Why?” Although the study wasn't designed to answer that question, analyzing the study data has given us a few ideas, including how the countries differ in the following:
Our data suggested that there were proportionally more lung transplants performed in Canada compared to the U.S. There is a substantial difference in how people are prioritized on the transplant list between the two countries. The U.S. system for allocation was put in place in 2005, which happened to be a point at which we noted a significant widening of the survival gap.
Health insurance status also seemed to affect survival. Canada has universal health care coverage, but the U.S. system is a combination of private and public health insurance. The data showed that people in the U.S. who:
Nutrition and lung function have been shown to be predictors of survival. In the 1970s, Canadians with CF were encouraged to eat a high-fat diet, which is associated with improved nutrition. The early implementation of the diet may have contributed to the survival gap because Canadian children born in the 1970s and early 1980s likely benefitted from that early exposure as they grew older. Learning from the Canadian practice, the U.S. implemented this approach to nutrition in the late 1980s. This practice is now standard around the world.
More needs to be done to better understand how these factors affect survival, and research is underway. The ongoing Canadian-U.S. collaboration is focusing on differences in lung function and nutrition among three age groups (6-19 years, 20-40 years, and 40 years and older), and how these have evolved over time.
Preliminary findings presented at the 2016 North American Cystic Fibrosis Conference showed that in 1990, Canadians with CF had better lung function and body mass index (an indicator of nutritional status) than Americans. However, from 1990 to 2013, the rate of improvement was greater in the U.S., so that by 2013, the gap between the two countries in these measures appears to have closed. Researchers in both countries are also examining the role of lung transplants in survival and in 2016, the CF Foundation launched an initiative to improve the results for lung transplants for those with CF in the U.S.
Stephenson AL, Sykes J, Stanojevic S, Quon BS, Marshall BC, Petren K, et al. Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study. Ann Intern Med. [Epub ahead of print 14 March 2017] doi: 10.7326/M16-0858. Copyright © 2017 American College of Physicians (ACP). Access to this article through the CF Foundation website (www.cff.org) is provided for personal, non-commercial use.
Christopher Goss, M.D., M.Sc.
Professor of Medicine and Pediatrics at the University of Washington
Chris is the associate adult CF care center director and does clinical work in adult pulmonary and critical care medicine. He co-directs the CF Foundation Therapeutics Development Network Coordinating Center at Seattle Children's Research Institute. He has been the chair of the Comparative Effectiveness Working Group for the CF Foundation since 2006.
Anne Stephenson, M.D., Ph.D.
Pulmonologist and Clinician Scientist, St. Michael's Hospital, and Assistant Professor, University of Toronto
Anne attended medical school and internal medicine training at the University of Toronto. She has worked in the adult CF program at St. Michael's Hospital since 2001. She is the director of the Canadian CF Registry and in addition to her clinical responsibilities, she conducts epidemiologic and health outcomes research in CF.
Share this Post
This site contains general information about cystic fibrosis, as well as personal insight from the CF community. It is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.
Follow Us On
Insurance, financial, legal, and other issues. A dedicated, knowledgeable CF Foundation Compass case manager is ready to work with you one-on-one.
Cystic Fibrosis Foundation
4550 Montgomery Ave.
Suite 1100 N
Bethesda, MD 20814
800-344-4823 (toll free)
Sign up for our emails